Business
Novartis Stock Plummets After Trial Disappointment
Shares of pharmaceutical giant Novartis dropped over 10% after its latest drug trial failed to meet expectations. The setback comes amid a series of disappointing results in recent weeks.
Coverage timeline — 2 articles
CNBC
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
2026-09-08 07:51 UTC
New Scientist
It is only natural to view the world, or even the entire universe, through the lens of humanity – we’re human, after all. But columnist Chanda Prescod-Weinstein says we can appreciate the wonder of the cosmos without inserting ourselves as a main character
2026-09-08 08:00 UTC